Hypertension in pregnancy among HIV-infected women in sub-Saharan Africa: prevalence and infant outcomes.

C. Kilewo, U. C. Natchu, A. Young, D. Donnell, E. Brown, J. S. Read, U. Sharma, B. H. Chi, R. Goldenberg, I. Hoffman, T. E. Taha, W. W. Fawzi

Research output: Contribution to journalArticlepeer-review

Abstract

This analysis was performed to determine the prevalence of hypertension and association of MAP (mean arterial pressure) with birth outcomes among HIV-infected pregnant women not taking antiretrovirals. HIV-infected pregnant women, enrolled into the HPTN024 trial in Tanzania, Malawi and Zambia were followed up at 26-30, 36 weeks, and delivery. The prevalence of hypertension was <1% at both 20-24 weeks and 26-30 weeks and 1.7% by 36 weeks. A 5 mm Hg elevation in MAP increased the risk of stillbirth at 20-24 weeks by 29% (p = 0.001), 32% (p = 0.001) at 26-30 weeks and of low birth weight (LBW) at 36 weeks by 26% (p = 0.001). MAP was not associated with stillbirth at 36 weeks, LBW prior to 36 weeks, preterm birth, neonatal mortality or the risk of maternal to child transmission (MTCT) of HIV.

Original languageEnglish (US)
Pages (from-to)25-36
Number of pages12
JournalAfrican Journal of Reproductive Health
Volume13
Issue number4
StatePublished - Dec 2009
Externally publishedYes

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology
  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'Hypertension in pregnancy among HIV-infected women in sub-Saharan Africa: prevalence and infant outcomes.'. Together they form a unique fingerprint.

Cite this